Your Notifications
All done, no notifications

What is Gastrointestinal Stromal Tumor (GIST)?

GIST, or gastrointestinal stromal tumour, is a cancer of the GI tract. It most often occurs in the stomach and small intestine. The tumours originate from specialised cells called interstitial cells of Cajal, which coordinate contractions of the smooth muscle in the digestive system.

What is the Importance of Timely Treatment?

  • Interception for the Growth and Spread of Tumors: Early treatment is an automatic metastasis prevention measure that prevents a tumour from spreading to other organs. Early intervention increases the likelihood of controlling the disease and enhances survival.
  • More Favorable Outcomes with Surgery: Tumors are much smaller, making surgery easier. This, in turn, means that the procedure is less risky and complicated. Early diagnosis ensures perfect resection, which is best for the cure.
  • Better Target Therapy Response: Prompt initiation of targeted therapy maximises its efficacy, especially in unresectable cases. Conversely, a delay in the institution of treatment can result in resistance and decrease the effectiveness of subsequent treatments.
  • Reduction in the Risk of Complication: Early treatment of GISTs would prevent complications such as bleeding and obstruction that weigh heavily on the patient's health and quality of life. An earlier address would ease these issues.
  • Improved Survival Rates: Patients with localised GISTs have better chances of long-term remission; whether this will be achieved depends on timely diagnosis and prompt intervention. Any delay in treatment would mean a more aggressive disease progression that shows a poor prognosis.

What are the Common Symptoms of Gastrointestinal Stromal Tumor (GIST)?

  • Abdominal Pain or Discomfort
  • Nausea and Vomiting
  • Weight Loss
  • GI Bleeding
  • A Palpable Abdominal Mass

Causes and Risk Factors of Gastrointestinal Stromal Tumor (GIST)

Causes

  • Genetic Mutations

Risk Factors

  • Genetic Syndromes
  • Age
  • Sex
  • Environmental Factors and Other Risks

Connect with our advisor for a PRIORITY response

Latest Research and Technologies in the Treatment of Gastrointestinal Stromal Tumor (GIST) in Thailand

Thailand provides advanced targeted therapies for the treatment of GIST without surgery. Personalised treatment regimens using gene mutation for testing are widely practised. Minimally invasive and robotic surgeries remove the tumours with fast recovery and minimum complications. Technologies like Proton Beam Therapy and Stereotactic Radiation Therapy are under investigation for these complex conditions. The latest trial on experimental treatments is to be partaken by the patients from Thai hospitals that join international clinical trials.

Gastrointestinal Stromal Tumor (GIST) Prevention Tip:

  • Genetic Counseling and Testing: Genetic counselling and testing should be considered if there's a family history of GISTs or condition-related genetic disorders such as Neurofibromatosis type 1.
  • Screening: People at increased risk, such as those who are older, have a family history of GISTs, or inherit genetic conditions, undergo imaging tests, such as CT scans, as part of a regular screening program to look for GIST at an early stage, thereby improving outcomes in treatment.
  • Leading Healthy Lifestyles: With the effects of well-being mentioned above, practising healthy eating, engaging in physical activities, and avoiding exposure to harmful or unnecessary things such as radiation should be advocated.
  • Signs and Symptoms: Keep in perspective the probable signs of GIST, including abdominal pain, nausea, loss of weight, and sanguineous vomit or intestinal bleeding. Early recognition and seeking medical assistance would allow for a quicker diagnosis and a much better outcome.

Treatment options for Gastrointestinal Stromal Tumor (GIST)

The medical treatment for Gastrointestinal Stromal Tumor (GIST) requires evaluating the patient's severity and medical condition. The following are the treatment options:

Surgery: The tumour should be resectable; the patient would be cured by a total resection under the best circumstances. Complications are more evident with larger tumours or those situated in areas that are technically challenging to access.

Targeted Therapy (TKIs) is the principal treatment modality for an advanced or metastatic GIST, targeting KIT and PDGFRA mutations. These agents exert their effect mainly on the intrinsic growth of the tumour cell and its ability to spread.


Cost Start From USD 3500Explore Options

Radiation Therapy: Radiation therapy for GIST treatment is not the standard due to GISTs being relatively resistant to it. It may be offered in rare instances for symptomatic relief or when surgery is contraindicated, such as for pain or obstruction.

Chemotherapy : Chemotherapy is usually ineffective for GISTs. Chemotherapy does not form a part of the treatment since GISTs respond poorly to familiar chemotherapeutic agents.


Cost Start From USD 1000 - USD 6800Explore Options

Immunotherapy and New Agents: Immunotherapy and new drugs are still being studied to treat resistant GISTs. Medications offer hope for the overcoming of resistance and improvement in treatment results.


Cost Start From USD 3000 - USD 13578Explore Options

These are the standard diagnostic methods for diagnosing Gastrointestinal Stromal Tumor (GIST):

Imaging Studies

  • CT Scan or Computed Tomography: The most common imaging studies done to diagnose GISTs are based on their size and location, extent of involvement and perhaps even whether any metastases have developed in the future.
  • MRI or Magnetic Resonance Imaging: Further characterisation is occasionally determined via a liver tumour or under suboptimal CT results.
  • Endoscopy: This may be used for tumours in the stomach or intestines if it can visualise the tumour directly and assess its size, ongoing obstruction, and bleeding.
  • Endoscopic Ultrasound (EUS): An EUS-guided biopsy can be done if the tumour lies in the GI tract, improving the quality of tissue samples.
  • PET Scan or Positron Emission Tomography: Assessing Metastasis PET scans can detect whether the GIST has spread to other body parts such as the liver or lung. It evaluates the metabolic activity of the tumour and verifies the response to treatment. Endoscopic Ultrasound

Biopsy

  • Fine Needle Aspiration (FNA): Small tissue samples are obtained from the tumour using a needle for microscopic examination. This will confirm the existence of GIST and eliminate others.
  • Core needle biopsy: A larger sample of tissue may be obtained in some cases using core needle biopsy to give more information on the structure of the tumour.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.

  • Physical Rehabilitation: Physiotherapy after surgery is vital to restore strength, flexibility and mobility. This procedure comprises exercises aimed at regaining muscle strength and reducing pain in the patient.
  • Nutrition support: The nutritionist personalises a program for the patient to meet any appetite and weight changes following treatment. Sometimes, supplementation protects against deficiencies from surgery.
  • Psychological Support: The counselling service helps to manage anxiety, depression, and stress during recovery. Through support groups, patients can find emotional support in one another's experiences, which benefits their mental wellness.
  • Checkup and Follow-Ups: Regular review by a doctor with the necessary imaging effectively detects GIST recurrence or metastasis over time.
  • Exercise and Medication Modification: Lifestyle modifications are based on aspects that help mitigate other treatment effects on patient wellness, managing stress and improving sleep performance to quality living.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Gastrointestinal Stromal Tumor (GIST) in Thailand

Bangkok Hospital: Top Doctors, and Reviews
Bangkok Hospital

Bangkok, Thailand

Bangkok Hospital located in Bangkok, Thailand is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • It is recognised for the application of the newest healthcare technology.
  • Blood analysis center that is not just the best in Thailand but in Asia Pacific as well.
  • Biomolecule center that is the seed of healthcare equipment for Thailand and overseas.
  • International affiliations and collaborations with universities and hospitals in Japan and the United States of America.
  • 11 hospitals are recognised as Centers of Excellence.
  • Known excellence in Trauma, Orthopedics, Cardiovascular, Neurology as well as Cancer Care.
  • There is a proper streamlined patient services process followed in Bangkok Dusit Medical Services, Bangkok, Thailand.
  • A well developed research center showcases the intent of the organisation to provide research based treatment opportunities to the patients.
  • The group has several Medical industry partnerships as well to ensure healthcare solutions.

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Thailand for Gastrointestinal Stromal Tumor (GIST) Treatment?

The following are the much-growing reasons for Thailand being frequented for Gastrointestinal Stromal Tumor (GIST) treatment:

  • Experienced Oncology Specialists: Thailand has a long list of well-trained oncologists, surgeons, and gastroenterologists who are experts in GIST management under disease-specific advanced treatment protocols.
  • Advanced Targeted Therapies: Thai hospitals offer the latest targeted medications, including genetic testing for personalised treatment.
  • State-of-the-Art Facilities: Internationally accredited hospitals in Thailand have advanced imaging, minimally invasive surgery, and robotic-assisted systems for precision care.
  • Affordable Treatment Costs: Thailand provides GIST treatment at substantially lower costs than Western countries, sometimes with world-class standards, making it the ideal country to visit and seek medical attention.
  • Access to Clinical Trials: Many leading cancer centres in Thailand are part of global clinical trials, allowing diseases to advance to newer therapies and innovative treatments.

Frequently Asked Questions

Since most GISTs are linked to genetic mutations, nothing is known to prevent them. However, genetic counselling and screening will aid in early detection if a family history with inherited conditions increases risk.

The prognosis of GISTs depends on several factors: the size and location of the tumour, the specific mutation type, and the degree of spread. Early-stage GISTs, when resected surgically, place their patients in a better prognostic category, while advanced ones require long-term therapy by medications.

Yes, GISTs can return, especially when the original tumour was large or had specific genetic mutation patterns. Therefore, regular follow-up imaging care is essential to detect these at the earliest signs of recurrence or metastasis.

The side effects from treatment, especially tyrosine kinase inhibitors (TKIs), can include fatigue, nausea, swelling, muscle cramps, and impairment of liver functions. These side effects should be controlled and managed according to the directions of the treating physician.

Novel medications have been established for treating GISTs that are resistant to other therapies, while studies are going on to combine targeted therapies with immunotherapy for improved management of advanced GISTs.

Yes, Thailand has several skilled oncologists and surgical specialists who are experienced with GIST. Most of them would have trained abroad and then been based on global guidelines for treatment.

Major hospitals in Thailand offer genetic mutation testing for KIT and PDGFRA genes. This helps in target-specific therapies, which yield better treatment outcomes.

Owing to the advanced therapies and expertise, there is a very high success rate regarding early-stage GIST cases in Thailand. Targeted therapy also proves suitable for the advanced type and helps improve survival benefits.